| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	HC Wainwright & Co. analyst Ananda Ghosh maintains PepGen (NASDAQ:PEPG) with a Buy and raises the price target from $12 ...
 
																	
 
																	
 
																	Wedbush analyst Laura Chico maintains PepGen (NASDAQ:PEPG) with a Outperform and lowers the price target from $9 to $8.
 
																	Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The m...
 
																	Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The ...
 
																	Stifel analyst Paul Matteis maintains PepGen (NASDAQ: PEPG) with a Buy and raises the price target from $9 to $12.
 
																	U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Thursday. The Dow traded ...
 
																	Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outst...